Caris Life Sciences
Caris Life Sciences, a leading innovator in the field of precision medicine, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2008, the company has established itself as a key player in the biotechnology industry, focusing on molecular profiling and advanced diagnostics to enhance cancer treatment. Caris Life Sciences offers a range of unique services, including comprehensive genomic profiling and biomarker testing, which empower healthcare providers to tailor therapies to individual patients. The company’s commitment to advancing personalised medicine has garnered recognition, positioning it as a trusted partner in oncology. With a robust portfolio of cutting-edge technologies, Caris Life Sciences continues to drive significant advancements in patient care and treatment outcomes.
DitchCarbon Score
How does Caris Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Caris Life Sciences's score of 3 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Caris Life Sciences's reported carbon emissions
Caris Life Sciences, headquartered in the US, currently does not have publicly available carbon emissions data for recent years, nor specific reduction targets or climate pledges outlined in their initiatives. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the company may still be engaged in industry-standard practices aimed at reducing environmental impact, which is increasingly important in the life sciences sector. As the industry moves towards greater sustainability, it is essential for companies like Caris Life Sciences to establish measurable targets and transparent reporting to contribute effectively to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Caris Life Sciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
